GRPR and glioblastoma: In an experimental study (164) using intracranial administration of the mouse glioblastoma cell line, CT-2A to make CNS tumors, the administration of the small molecule 77427, which is a GRPR antagonist, inhibited angiogenesis, and smaller tumors developed.